The UK Biobank cohort comprised 9.1 million eligible individuals, 8.6 million of which did not respond or did not provide consent. Thus, at baseline, the UK Biobank included 502,478 Britons (5.5% of the total UK Biobank cohort), aged 38–73 years, across 22 UK cities from the UK National Health Service Register between 2006 and 2010, 90 M of which were linked to national health registries. Participants responded to questionnaires and a computer-assisted interview, and they were subject to physical and functional measures and blood, urine, and saliva sampling [16 (link)]. Data included personalized information of the participants, including socio-economic, behavior and lifestyle, mental health battery, clinical diagnoses and therapies, genetics, imaging and physiological biomarkers from blood and urine samples. The cohort protocol can be found in the literature [17 (link),18 (link)].
Free full text: Click here
